Rezolute Announces Appointment of Congenital Hyperinsulinism Therapeutic Area Expert, Dr. Christine Ferrara, as Director of Clinical Development

Stock Information for Rezolute Inc

Loading

Please wait while we load your information from QuoteMedia.